{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:37:19Z","timestamp":1762004239034},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T00:00:00Z","timestamp":1273708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s10495-010-0508-6","type":"journal-article","created":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T08:17:30Z","timestamp":1273652250000},"page":"956-965","source":"Crossref","is-referenced-by-count":31,"title":["Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer"],"prefix":"10.1007","volume":"15","author":[{"given":"Jo\u00e3o R.","family":"Carvalho","sequence":"first","affiliation":[]},{"given":"Lu\u00edsa","family":"Filipe","sequence":"additional","affiliation":[]},{"given":"Vera L.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Franclim Ricardo","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Ana T.","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Manuel R.","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,5,13]]},"reference":[{"key":"508_CR1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.molmed.2006.06.002","volume":"12","author":"E Bremer","year":"2006","unstructured":"Bremer E, van Dam G, Kroesen BJ, de Leij L, Helfrich W (2006) Targeted induction of apoptosis for cancer therapy: current progress and prospects. Trends Mol Med 12:382\u2013393","journal-title":"Trends Mol Med"},{"key":"508_CR2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nrd2637","volume":"7","author":"A Ashkenazi","year":"2008","unstructured":"Ashkenazi A (2008) Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nat Rev Drug Discov 7:1001\u20131012","journal-title":"Nat Rev Drug Discov"},{"key":"508_CR3","first-page":"117","volume":"1795","author":"S Hector","year":"2009","unstructured":"Hector S, Prehn JH (2009) Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review. Biochim Biophys Acta 1795:117\u2013129","journal-title":"Biochim Biophys Acta"},{"key":"508_CR4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57\u201370","journal-title":"Cell"},{"key":"508_CR5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225\u2013249","journal-title":"CA Cancer J Clin"},{"key":"508_CR6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMra021562","volume":"349","author":"WG Nelson","year":"2003","unstructured":"Nelson WG, De Marzo AM, Isaacs WB (2003) Prostate cancer. N Engl J Med 349:366\u2013381","journal-title":"N Engl J Med"},{"key":"508_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1677\/erc.0.0090087","volume":"9","author":"XK Zhang","year":"2002","unstructured":"Zhang XK (2002) Vitamin A and apoptosis in prostate cancer. Endocr Relat Cancer 9:87\u2013102","journal-title":"Endocr Relat Cancer"},{"key":"508_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/ERC-07-0208","volume":"15","author":"TM Murphy","year":"2008","unstructured":"Murphy TM, Perry AS, Lawler M (2008) The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer. Endocr Relat Cancer 15:11\u201325","journal-title":"Endocr Relat Cancer"},{"key":"508_CR9","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1158\/1078-0432.CCR-04-0930","volume":"10","author":"MG Friedrich","year":"2004","unstructured":"Friedrich MG, Weisenberger DJ, Cheng JC et al (2004) Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin Cancer Res 10:7457\u20137465","journal-title":"Clin Cancer Res"},{"key":"508_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1155\/2007\/356742","volume":"23","author":"VL Costa","year":"2007","unstructured":"Costa VL, Henrique R, Jeronimo C (2007) Epigenetic markers for molecular detection of prostate cancer. Dis Markers 23:31\u201341","journal-title":"Dis Markers"},{"key":"508_CR11","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1158\/1078-0432.CCR-04-0894","volume":"10","author":"C Jeronimo","year":"2004","unstructured":"Jeronimo C, Henrique R, Hoque MO et al (2004) A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 10:8472\u20138478","journal-title":"Clin Cancer Res"},{"key":"508_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/b137945","volume-title":"TNM atlas: illustrated guide to the TNM\/pTNM classification of malignant tumours","author":"CF Wittekind","year":"2005","unstructured":"Wittekind CF, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH (2005) Prostate. In: Wittekind CF, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH (eds) TNM atlas: illustrated guide to the TNM\/pTNM classification of malignant tumours, 5th edn. Springer, Berlin, pp 283\u2013291","edition":"5"},{"key":"508_CR13","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1158\/1055-9965.EPI-04-0659","volume":"14","author":"R Henrique","year":"2005","unstructured":"Henrique R, Jeronimo C, Hoque MO et al (2005) MT1G hypermethylation is associated with higher tumor stage in prostate cancer. Cancer Epidemiol Biomarkers Prev 14:1274\u20131278","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"508_CR14","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1093\/nar\/28.8.e32","volume":"28","author":"CA Eads","year":"2000","unstructured":"Eads CA, Danenberg KD, Kawakami K et al (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28:E32","journal-title":"Nucleic Acids Res"},{"key":"508_CR15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.cdd.4401132","volume":"10","author":"I Petak","year":"2003","unstructured":"Petak I, Danam RP, Tillman DM et al (2003) Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma. Cell Death Differ 10:211\u2013217","journal-title":"Cell Death Differ"},{"key":"508_CR16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.cdd.4401157","volume":"10","author":"S Hopkins-Donaldson","year":"2003","unstructured":"Hopkins-Donaldson S, Ziegler A, Kurtz S et al (2003) Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ 10:356\u2013364","journal-title":"Cell Death Differ"},{"key":"508_CR17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/cyto.1999.0585","volume":"12","author":"MP Miguel de","year":"2000","unstructured":"de Miguel MP, Royuela M, Bethencourt FR, Santamaria L, Fraile B, Paniagua R (2000) Immunoexpression of tumour necrosis factor-alpha and its receptors 1 and 2 correlates with proliferation\/apoptosis equilibrium in normal, hyperplasic and carcinomatous human prostate. Cytokine 12:535\u2013538","journal-title":"Cytokine"},{"key":"508_CR18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/pros.20421","volume":"66","author":"V Hesry","year":"2006","unstructured":"Hesry V, Piquet-Pellorce C, Travert M et al (2006) Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players. Prostate 66:987\u2013995","journal-title":"Prostate"},{"key":"508_CR19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pros.1061","volume":"47","author":"AJ O\u2019Neill","year":"2001","unstructured":"O\u2019Neill AJ, Boran SA, O\u2019Keane C et al (2001) Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma. Prostate 47:183\u2013188","journal-title":"Prostate"},{"key":"508_CR20","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.molimm.2005.11.010","volume":"43","author":"G Gopisetty","year":"2006","unstructured":"Gopisetty G, Ramachandran K, Singal R (2006) DNA methylation and apoptosis. Mol Immunol 43:1729\u20131740","journal-title":"Mol Immunol"},{"key":"508_CR21","first-page":"6634","volume":"62","author":"U Lehmann","year":"2002","unstructured":"Lehmann U, Celikkaya G, Hasemeier B, Langer F, Kreipe H (2002) Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype. Cancer Res 62:6634\u20136638","journal-title":"Cancer Res"},{"key":"508_CR22","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1158\/0008-5472.CAN-03-3972","volume":"64","author":"S Yegnasubramanian","year":"2004","unstructured":"Yegnasubramanian S, Kowalski J, Gonzalgo ML et al (2004) Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 64:1975\u20131986","journal-title":"Cancer Res"},{"key":"508_CR23","first-page":"514","volume":"8","author":"R Maruyama","year":"2002","unstructured":"Maruyama R, Toyooka S, Toyooka KO et al (2002) Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 8:514\u2013519","journal-title":"Clin Cancer Res"},{"key":"508_CR24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0959-8049(01)00355-0","volume":"38","author":"TJ Zuzak","year":"2002","unstructured":"Zuzak TJ, Steinhoff DF, Sutton LN, Phillips PC, Eggert A, Grotzer MA (2002) Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour\/medulloblastoma. Eur J Cancer 38:83\u201391","journal-title":"Eur J Cancer"},{"key":"508_CR25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4161\/cbt.1.1.45","volume":"1","author":"N Shivapurkar","year":"2002","unstructured":"Shivapurkar N, Toyooka S, Eby MT et al (2002) Differential inactivation of caspase-8 in lung cancers. Cancer Biol Ther 1:65\u201369","journal-title":"Cancer Biol Ther"},{"key":"508_CR26","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0016-5085(03)01059-X","volume":"125","author":"HS Kim","year":"2003","unstructured":"Kim HS, Lee JW, Soung YH et al (2003) Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 125:708\u2013715","journal-title":"Gastroenterology"},{"key":"508_CR27","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1158\/0008-5472.CAN-08-3937","volume":"69","author":"S Barbero","year":"2009","unstructured":"Barbero S, Mielgo A, Torres V et al (2009) Caspase-8 association with the focal adhesion complex promotes tumor cell migration and metastasis. Cancer Res 69:3755\u20133763","journal-title":"Cancer Res"},{"key":"508_CR28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/pros.20371","volume":"66","author":"RL Collard","year":"2006","unstructured":"Collard RL, Harya NS, Monzon FA, Maier CE, O\u2019Keefe DS (2006) Methylation of the ASC gene promoter is associated with aggressive prostate cancer. Prostate 66:687\u2013695","journal-title":"Prostate"},{"key":"508_CR29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1476-4598-5-28","volume":"5","author":"PM Das","year":"2006","unstructured":"Das PM, Ramachandran K, Vanwert J et al (2006) Methylation mediated silencing of TMS1\/ASC gene in prostate cancer. Mol Cancer 5:28","journal-title":"Mol Cancer"},{"key":"508_CR30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2005.11.002","volume":"242","author":"M Suzuki","year":"2006","unstructured":"Suzuki M, Shigematsu H, Shivapurkar N et al (2006) Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer. Cancer Lett 242:222\u2013230","journal-title":"Cancer Lett"},{"key":"508_CR31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0006-291X(03)00309-7","volume":"303","author":"J Masumoto","year":"2003","unstructured":"Masumoto J, Dowds TA, Schaner P et al (2003) ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochem Biophys Res Commun 303:69\u201373","journal-title":"Biochem Biophys Res Commun"},{"key":"508_CR32","first-page":"1567","volume":"148","author":"M Krajewska","year":"1996","unstructured":"Krajewska M, Krajewski S, Epstein JI et al (1996) Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 148:1567\u20131576","journal-title":"Am J Pathol"},{"key":"508_CR33","first-page":"390","volume":"143","author":"M Colombel","year":"1993","unstructured":"Colombel M, Symmans F, Gil S et al (1993) Detection of the apoptosis-suppressing oncoprotein bc1\u20132 in hormone-refractory human prostate cancers. Am J Pathol 143:390\u2013400","journal-title":"Am J Pathol"},{"key":"508_CR34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ncpuro0099","volume":"2","author":"NJ Mackler","year":"2005","unstructured":"Mackler NJ, Pienta KJ (2005) Drug insight: use of docetaxel in prostate and urothelial cancers. Nat Clin Pract Urol 2:92\u2013100","journal-title":"Nat Clin Pract Urol"},{"key":"508_CR35","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-06-0147","volume":"12","author":"T Yoshino","year":"2006","unstructured":"Yoshino T, Shiina H, Urakami S et al (2006) Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy. Clin Cancer Res 12:6116\u20136124","journal-title":"Clin Cancer Res"},{"key":"508_CR36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/(SICI)1097-0215(19970127)70:3<341::AID-IJC16>3.0.CO;2-I","volume":"70","author":"N Kyprianou","year":"1997","unstructured":"Kyprianou N, King ED, Bradbury D, Rhee JG (1997) bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int J Cancer 70:341\u2013348","journal-title":"Int J Cancer"},{"key":"508_CR37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/path.2106","volume":"211","author":"NY Cho","year":"2007","unstructured":"Cho NY, Kim BH, Choi M et al (2007) Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. J Pathol 211:269\u2013277","journal-title":"J Pathol"},{"key":"508_CR38","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1038\/sj.onc.1204926","volume":"20","author":"SD Catz","year":"2001","unstructured":"Catz SD, Johnson JL (2001) Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 20:7342\u20137351","journal-title":"Oncogene"},{"key":"508_CR39","doi-asserted-by":"crossref","unstructured":"Vinci S, Giannarini G, Selli C, et al. (2009) Quantitative methylation analysis of BCL2, hTERT, and DAPK promoters in urine sediment for the detection of non-muscle-invasive urothelial carcinoma of the bladder: a prospective, two-center validation study. Urol Oncol. doi: 10.1016\/j.urolonc.2009.01.003","DOI":"10.1016\/j.urolonc.2009.01.003"},{"key":"508_CR40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/labinvest.3700707","volume":"88","author":"GH Kang","year":"2008","unstructured":"Kang GH, Lee S, Cho NY et al (2008) DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis. Lab Invest 88:161\u2013170","journal-title":"Lab Invest"},{"key":"508_CR41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mc.1062","volume":"32","author":"S Santourlidis","year":"2001","unstructured":"Santourlidis S, Warskulat U, Florl AR et al (2001) Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95\/Apo-1) gene promoter at rel\/nuclear factor kappaB sites in prostatic carcinoma. Mol Carcinog 32:36\u201343","journal-title":"Mol Carcinog"},{"key":"508_CR42","doi-asserted-by":"crossref","first-page":"D149","DOI":"10.1093\/nar\/gkm995","volume":"36","author":"D Betel","year":"2008","unstructured":"Betel D, Wilson M, Gabow A, Marks DS, Sander C (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36:D149\u2013D153","journal-title":"Nucleic Acids Res"},{"key":"508_CR43","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0022-5347(05)00160-6","volume":"175","author":"HF O\u2019Kane","year":"2006","unstructured":"O\u2019Kane HF, Watson CJ, Johnston SR, Petak I, Watson RW, Williamson KE (2006) Targeting death receptors in bladder, prostate and renal cancer. J Urol 175:432\u2013438","journal-title":"J Urol"},{"key":"508_CR44","first-page":"3068","volume":"59","author":"SH Lee","year":"1999","unstructured":"Lee SH, Shin MS, Park WS et al (1999) Alterations of Fas (APO-1\/CD95) gene in transitional cell carcinomas of urinary bladder. Cancer Res 59:3068\u20133072","journal-title":"Cancer Res"},{"key":"508_CR45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/labinvest.3780236","volume":"81","author":"H Takayama","year":"2001","unstructured":"Takayama H, Takakuwa T, Dong Z et al (2001) Fas gene mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of laser capture microdissected specimens. Lab Invest 81:283\u2013288","journal-title":"Lab Invest"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-010-0508-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-010-0508-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-010-0508-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T14:41:17Z","timestamp":1559140877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-010-0508-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,13]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1007\/s10495-010-0508-6","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,13]]}}}